During the past decade, Utah Cardiology, P.C. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 9 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Utah Cardiology, P.C." #1 sponsor was "Pfizer" with 5 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Angiodynamics, Inc." with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Utah Cardiology, P.C." #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Utah Cardiology, P.C." are "Cardiovascular Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Hyperlipidemia" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Kidney Injury" (1 trials). Many other conditions were trialed in "Utah Cardiology, P.C." in a lesser frequency.

Most popular intervention types in "Utah Cardiology, P.C." are "Drug" (10 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (2 trials), "Bococizumab (PF-04950615;RN316)" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Utah Cardiology, P.C." are 11 trials for "All" genders.

Currently, there are NaN active trials in "Utah Cardiology, P.C.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Utah Cardiology, P.C., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Utah Cardiology, P.C., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".